Leigh Ellis Selected Research

MAP Kinase Kinase 7

1/2022

Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leigh Ellis Research Topics

Disease

36	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2011
34	Neoplasms (Cancer) 03/2022 - 07/2008
7	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2010
4	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 06/2010
4	Hypoxia (Hypoxemia) 01/2019 - 08/2009
3	Adenocarcinoma 01/2021 - 01/2011
1	Bites and Stings (Sting) 01/2021
1	Prostatic Intraepithelial Neoplasia 12/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Melanoma (Melanoma, Malignant) 02/2015
1	Disease Progression 05/2012

Drug/Important Bio-Agent (IBA)

17	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 01/2011
12	AndrogensIBA 10/2021 - 01/2011
7	Histone Deacetylase InhibitorsIBA 01/2012 - 07/2008
5	Proteins (Proteins, Gene)FDA Link 11/2017 - 12/2013
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 08/2010
4	Androgen Antagonists (Antiandrogens)IBA 01/2020 - 01/2017
4	PanobinostatIBA 01/2011 - 07/2008
3	Transcription Factors (Transcription Factor)IBA 10/2021 - 11/2019
3	Histones (Histone)IBA 12/2020 - 06/2009
3	enzalutamideIBA 11/2019 - 01/2017
3	ChromatinIBA 01/2019 - 06/2009
2	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 11/2017
2	EnzymesIBA 01/2019 - 06/2009
2	VaccinesIBA 12/2017 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 06/2009
2	Etoposide (VP 16)FDA LinkGeneric 01/2016 - 02/2015
2	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 01/2011
2	Everolimus FDA Link 02/2012 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2010 - 08/2009
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	MAP Kinase Kinase 7IBA 01/2022
1	tdTomatoIBA 10/2021
1	salicylhydroxamic acid (SHAM)IBA 10/2021
1	Epithelial Cell Adhesion MoleculeIBA 10/2021
1	LuciferasesIBA 10/2021
1	olaparibIBA 01/2021
1	cyclopropapyrroloindoleIBA 01/2021
1	Heme (Haem)IBA 01/2021
1	InterferonsIBA 01/2021
1	Ribose (D-Ribose)IBA 01/2021
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Androgen Receptor AntagonistsIBA 11/2019
1	TH 302IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	abirateroneIBA 01/2019
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2019
1	ProdrugsIBA 01/2019
1	A-Form DNA (A-DNA)IBA 12/2017
1	LigandsIBA 12/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	Radioisotopes (Radionuclides)IBA 11/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2016
1	Connexin 43 (Connexin43)IBA 05/2015
1	ConnexinsIBA 05/2015
1	GSK-2816126IBA 02/2015
1	PoisonsIBA 02/2015
1	3-deazaneplanocinIBA 02/2015
1	RNA (Ribonucleic Acid)IBA 02/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2015
1	Cancer VaccinesIBA 02/2015
1	SuperantigensIBA 02/2015
1	tasquinimodIBA 02/2015
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2014
1	Docetaxel (Taxotere)FDA Link 01/2014
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	dactolisibIBA 12/2013
1	Topoisomerase I InhibitorsIBA 11/2012
1	CamptothecinIBA 11/2012
1	CyclodextrinsIBA 11/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2012
1	Acetic Acid (Vinegar)FDA LinkGeneric 02/2012
1	MTOR InhibitorsIBA 02/2012
1	vadimezanIBA 02/2012
1	entinostat (MS 275)IBA 01/2012
1	Interleukin-2 (IL2)IBA 01/2012
1	SurvivinIBA 01/2012
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2011
1	MicroRNAs (MicroRNA)IBA 01/2011

Therapy/Procedure

26	Therapeutics 03/2022 - 06/2009
10	Castration 01/2022 - 01/2012
6	Immunotherapy 03/2022 - 01/2012
2	Aftercare (After-Treatment) 01/2021 - 07/2009
1	Prostatectomy (Retropubic Prostatectomy) 09/2021
1	Oral Administration 01/2021
1	Chemoprevention 12/2020
1	Precision Medicine 01/2020
1	Nephrectomy 01/2016
1	Drug Therapy (Chemotherapy) 01/2014
1	Subcutaneous Injections 05/2012